Search results for "polycystic ovary syndrome"

showing 10 items of 126 documents

Metabolic and cardiopulmonary effects of detraining after a structured exercise training programme in young PCOS women

2008

Summary Objective  The aim of the present study was to determine if the favourable cardiopulmonary and metabolic benefits induced by exercise training (ET) programme are maintained after its cessation. Patients  Thirty-two young overweight polycystic ovary syndrome (PCOS) women matched for age and body mass index (BMI) with other 32 PCOS patients was enrolled. The first group [PCOS-T (trained)] underwent 24-week ET programme, whereas the second [PCOS-DT (detrained)] underwent 12-week ET programme followed by 12-week detraining period. Methods  At baseline, after 12- and 24-week follow-up, all PCOS women were studied for their hormonal (ovarian and adrenal androgens), metabolic (glucose and …

Blood GlucoseSettore MED/09 - Medicina Internaendocrine system diseasescardiopulmonary effectsEndocrinology Diabetes and Metabolismmedicine.medical_treatmentOverweightSettore MED/13 - EndocrinologiaBody Mass IndexEndocrinologyInsulinmedicine.diagnostic_testVO2 maxPCOS womenPolycystic ovaryfemale genital diseases and pregnancy complicationsRespiratory Function TestsCholesterolHeart Function Testspolicystic ovary syndromeFemalemedicine.symptomPhysical exercise training cardiovascular function pulmonary function PCOS hyperandrogenism insulin resistanceSettore M-EDF/01 - Metodi E Didattiche Delle Attivita' MotoriePolycystic Ovary Syndromemedicine.medical_specialtyexercise training programmeLipoproteinsPhysical exerciseOxygen ConsumptionInternal medicinemedicineHumansExercise physiologyExerciseTriglyceridescardiopulmonary functionbusiness.industryInsulinMetabolic effects; cardiopulmonary effects; exercise training programme; PCOS womennutritional and metabolic diseasesOverweightCardiovascular riskSettore MED/11 - Malattie Dell'Apparato CardiovascolareMetabolic effectsEndocrinologystructured exercise training programmebusinessLipid profileBody mass index
researchProduct

Effects of oral contraceptives on metabolic profile in women with polycystic ovary syndrome: A meta-analysis comparing products containing cyproteron…

2017

Abstract Background Although oral contraceptives (OCs) are the most common treatment in women with polycystic ovary syndrome (PCOS), their effects and safety on the metabolic profiles of these patients are relatively unknown. In this meta-analysis the effects of the different durations (from 3 months to 1 year) of OC treatment using cyproterone acetate (CA) or third generation progestins on metabolic profile of patients with PCOS were assessed. Materials and methods PubMed, Scopus, Google Scholar and ScienceDirect databases (2001–2015) were searched to identify clinical trials investigating the effects of OC containing CA or third generation progestins on metabolic profiles of women with PC…

Blood Glucosemedicine.medical_specialtyTime Factorsmedicine.drug_classEndocrinology Diabetes and MetabolismBlood lipidsBlood Pressure030209 endocrinology & metabolism03 medical and health scienceschemistry.chemical_compound0302 clinical medicineEndocrinologyInsulin resistanceDesogestrelInternal medicinemedicineHumansInsulinCyproterone AcetateClinical Trials as Topic030219 obstetrics & reproductive medicinebusiness.industryBody WeightCyproterone acetateDrospirenoneLipid Metabolismmedicine.diseasePolycystic ovaryEndocrinologychemistryMetabolomeFemaleProgestinsbusinessProgestinBody mass indexContraceptives OralPolycystic Ovary Syndromemedicine.drugMetabolism
researchProduct

Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome

2003

To determine the prevalence of insulin resistance (IR) in women with polycystic ovary syndrome (PCOS) using baseline fasting blood measurements of glucose and insulin. Prospective clinical study. Academic endocrinology unit in Palermo, Italy. Two hundred and sixty-seven women with PCOS, consecutively evaluated, and 50 consecutively selected ovulating controls. Fasting blood was obtained for glucose and insulin measurements from all women. For 60 women with PCOS and 20 controls an insulin tolerance test (ITT) was also performed. Assessment of normal and abnormal values for fasting insulin, glucose/insulin ratio, and the calculated indices of the homeostasis model assessment (HOMA), quantitat…

Blood Glucosemedicine.medical_specialtyendocrine system diseasesmedicine.medical_treatmentFasting insulinInsulin resistanceReference ValuesInternal medicinemedicineHomeostasisHumansInsulinPancreatic hormoneRetrospective Studiesbusiness.industryInsulinQuantitative insulin sensitivity check indexInsulin tolerance testInsulin Resistance Fasting physiology Insulin blood Polycystic Ovary SyndromeObstetrics and GynecologyFastingmedicine.diseasePolycystic ovaryEndocrinologyReproductive MedicineFemaleInsulin ResistancebusinessBody mass indexPolycystic Ovary Syndrome
researchProduct

Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guidelin…

2006

OBJECTIVE: The Androgen Excess Society (AES) charged a task force to review all available data and recommend an evidence-based definition for polycystic ovary syndrome (PCOS), whether already in use or not, to guide clinical diagnosis and future research. PARTICIPANTS: Participants included expert investigators in the field. EVIDENCE: Based on a systematic review of the published peer-reviewed medical literature, by querying MEDLINE databases, we tried to identify studies evaluating the epidemiology or phenotypic aspects of PCOS. CONSENSUS PROCESS: The task force drafted the initial report, following a consensus process via electronic communication, which was then reviewed and critiqued by …

ConsensusAndrogensHumansFemaleGuidelines as TopicHyperandrogenismSocieties Medicalpolycystic ovary syndrome cardiovascular risk insulin resistancePolycystic Ovary SyndromeThe Journal of clinical endocrinology and metabolism
researchProduct

Let's rescue oocytes: in vitro maturation 2.0 is coming

2018

Cumulus Cells030219 obstetrics & reproductive medicineObstetrics and Gynecology030209 endocrinology & metabolismBiologyFollicular FluidCell biologyIn vitro maturation03 medical and health sciences0302 clinical medicineReproductive MedicineOocytesHumansFemalePolycystic Ovary SyndromeFertility and Sterility
researchProduct

Diagnosis of polycystic ovary syndrome: from NIH criteria to ESHRE-ASRM guidelines.

2004

In the past, the diagnosis of polycystic ovary syndrome (PCOS) was based on National Institute of Health (NIH) criteria (hyperandrogenism and chronic anovulation) or on sonographic findings of polycystic ovaries. Diffe-rences in diagnosis criteria made it difficult to compare the data of studies coming from different countries. Moreover, there was criticism of both the methods used. In 2003, at a joint meeting of the European Society for Human Reproduction (ESHRE) and the American Society of Reproductive Medicine (ASRM), new guidelines for the diagnosis of PCOS were suggested. According to these guidelines, it is possible to reach a diagnosis of PCOS when at least 2 of these 3 elements are …

Diagnosis DifferentialEuropeNational Institutes of Health (U.S.)Practice Guidelines as TopicHumansFemalePractice GuidelinesHyperandrogenismUnited StatesAnovulationPolycystic Ovary SyndromeUltrasonographyMinerva ginecologica
researchProduct

Adjuncts for ovarian stimulation: when do we adopt “orphan indications” for approved drugs?

2009

Several drugs, shown to be safe for other uses, have proven to be highly effective adjuncts for ovarian stimulation. The authors evaluate these "orphan" indications and make recommendations so that more patients will benefit from their use.

Drugendocrine systemmedicine.medical_specialtyOrphan Drug ProductionResearch methodologymedia_common.quotation_subjectFertilization in VitroReproductive technologyAcide acétylsalicyliqueHealth servicesProstaglandin-Endoperoxide SynthaseOvulation InductionHumansMedicineIntensive care medicinemedia_commonGynecologyAspirinHuman Growth Hormonebusiness.industryObstetrics and GynecologyErgot DerivativesEstrogensMetforminReproductive MedicineDopamine AgonistsAndrogensFemaleFertility agentsLeuprolidebusinessContraceptives OralPolycystic Ovary SyndromeFertility and Sterility
researchProduct

Metformin induces lipid changes on sphingolipid species and oxidized lipids in polycystic ovary syndrome women.

2019

Metformin is one of the treatments used for pcoS pathology decreasing body weight, plasma androgen, FSH and glucose levels. Unfortunately, there is little known about metformin’s effects on lipid metabolism, a crucial process in pcoS pathology. We have employed a lipidomic approach to explore alterations in the plasma lipid profile of patients with PCOS following metformin treatment. The aim is to offer new insights about the effect of metformin in PCOS patients. Plasma samples were obtained from 27 subjects prior to and following 12 weeks of metformin treatment. A detailed biochemical characterization and lipidomic profile was performed. Metformin reduces BMI, HOMA-IR, fSH and androstenedi…

Endocrine reproductive disordersmedicine.medical_specialtyendocrine system diseasesmedicine.drug_classlcsh:Medicinemedicine.disease_causeArticleInternal medicinemedicineHumansAndrostenedionelcsh:ScienceSphingolipidsMultidisciplinarybusiness.industrylcsh:Rdigestive oral and skin physiologynutritional and metabolic diseasesLipid metabolismMetabolismAndrogenSphingolipidPolycystic ovaryMetforminMetforminOxidative StressEndocrinologyLipidomicslcsh:QFemalebusinessOxidation-ReductionOxidative stressmedicine.drugPolycystic Ovary SyndromeScientific reports
researchProduct

HDlive ultrasound images in assisted reproduction treatment.

2012

Abstract The volume ultrasound technology software known as the HDlive technique represents an innovative tool, a step towards an even more realistic anatomical visualization of pelvic organ structures. HDlive can help improve physician–patient communication with the aid of life-like images and might prove useful in the field of assisted reproduction treatment. The clinical application of this novel ultrasound technology in assisted reproduction treatment deserves scientific evaluation.

GynecologyAdultPelvic organmedicine.medical_specialtymedicine.diagnostic_testReproductive Techniques Assistedbusiness.industryUltrasoundOvaryObstetrics and GynecologyVisualizationReproductive MedicineOvulation InductionImage Processing Computer-AssistedMedicineHumans3D ultrasoundMedical physicsFemalebusinessSoftwareDevelopmental BiologyPolycystic Ovary SyndromeUltrasonographyReproductive biomedicine online
researchProduct

The diagnosis of polycystic ovary syndrome in adolescents

2010

In women, the definition of polycystic ovary syndrome (PCOS) has become broad and includes several possible phenotypes. Because several features of PCOS may be in evolution in adolescents, we suggest that only firm criteria should be used to make a diagnosis of PCOS during adolescence. Hyperandrogenism, oligomenorrhea, and ovarian morphology change during adolescence and are discussed individually. Adolescents with incomplete criteria for a firm diagnosis of PCOS should be followed up carefully and may be diagnosed at a later time.

Hirsutismmedicine.medical_specialtyAdolescentendocrine system diseasesMEDLINESettore MED/13 - EndocrinologiamedicineHumansCystAmenorrheaUltrasonographyMenarcheGynecologybusiness.industryOvaryPubertyHyperandrogenismnutritional and metabolic diseasesObstetrics and Gynecologymedicine.diseasePolycystic ovaryfemale genital diseases and pregnancy complicationsOligomenorrheaOvarian morphologyMenarcheFemaleUltrasonographyHyperandrogenismbusinessPOLYCYSTIC OVARY SYNDROME ADOLESCENCE MENSTRUAL IRREGULARITIES HIRSUTISMAnovulationPolycystic Ovary Syndrome
researchProduct